Carregant...
Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial
Background: Proinflammatory cytokines, especially tumour necrosis factor α (TNF-α), play a prominent role in the pathogenesis of cancer cachexia. Thalidomide, which is an inhibitor of TNF-α synthesis, may represent a novel and rational approach to the treatment of cancer cachexia. Aims: To assess th...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Copyright 2005 by Gut
2005
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1774430/ https://ncbi.nlm.nih.gov/pubmed/15753541 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2004.047563 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|